AIMS : Ezetimibe reduces plasma levels of low-density lipoprotein ( LDL ) cholesterol by inhibiting Niemann-Pick C1-Like protein 1 ( NPC1L1 ) , the transporter responsible for cholesterol uptake from the intestine into enterocytes and from the bile into hepatocytes .